<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener("load", function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <iframe src="http://www.blogger.com/navbar.g?targetBlogID=6223270&amp;blogName=James+Hatton+on+licensing&amp;publishMode=PUBLISH_MODE_FTP&amp;navbarType=BLUE&amp;layoutType=CLASSIC&amp;homepageUrl=http%3A%2F%2Fwww.jameshatton.com%2Fpublic%2F&amp;blogLocale=en_CA&amp;searchRoot=http%3A%2F%2Fblogsearch.google.com%2F" marginwidth="0" marginheight="0" scrolling="no" frameborder="0" height="30px" width="100%" id="navbar-iframe" title="Blogger Navigation and Search"></iframe> <div></div>

Monday, December 29, 2008

The most important alliances of 2008 per Recap.com

I am collecting the most important alliances of 2008 from a few reliable sources.

First, from the Recap.com | Allicense 2008 - Ballot Page: The "Breakthrough alliance" winner was

Bristol-Myers Squibb/Adnexus

The nominees were (links are to the full text of the agreements):

CompaniesDateDeal
Bristol-Myers Squibb/Adnexus2/07Discovery and Development of Adnectin-Based Therapeutics in Oncology
Merck/Ariad Pharmaceuticals7/07Defrolimus mTOR Inhibitor for Treatment of Cancer
Ortho-McNeil/ISIS Pharmaceuticals9/07Antisense Drugs to Treat Metabolic Diseases
Roche/Alnylam Pharmaceuticals7/07Discovery and Development of RNAi Therapeutics
Sanofi-Aventis/Regeneron Pharmaceuticals11/07Co-Development of Fully-Human Therapeutic Antibodies

8:34 PM

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home